$JNJ pushing up timeline for clinical trials from Sept to July.
@IAmBiotech, CSO Paul Stoffels said while J&amp;J has capacity for large scale trials, its "a Herculean task" to test in "a placebo controlled way with good efficacy points and using good labs."
https://t.co/T3bPx9o0Qz